Laurent Dortet Selected Research

carbapenemase

2/2022	Specificities and Commonalities of Carbapenemase-Producing Escherichia coli Isolated in France from 2012 to 2015.
12/2020	Carbapenemase-producing Enterobacterales outbreak: Another dark side of COVID-19.
1/2020	Optimization of the MALDIxin test for the rapid identification of colistin resistance in Klebsiella pneumoniae using MALDI-TOF MS.
11/2018	Rapid detection of colistin resistance in Acinetobacter baumannii using MALDI-TOF-based lipidomics on intact bacteria.
1/2018	Higher Prevalence of PldA, a Pseudomonas aeruginosa Trans-Kingdom H2-Type VI Secretion System Effector, in Clinical Isolates Responsible for Acute Infections and in Multidrug Resistant Strains.
1/2018	CTX-M-15-Producing Shewanella Species Clinical Isolate Expressing OXA-535, a Chromosome-Encoded OXA-48 Variant, Putative Progenitor of the Plasmid-Encoded OXA-436.
1/2018	Novel Enterobacter Lineage as Leading Cause of Nosocomial Outbreak Involving Carbapenemase-Producing Strains.
1/2017	Chromosomal Amplification of the blaOXA-58 Carbapenemase Gene in a Proteus mirabilis Clinical Isolate.
11/2015	Dissemination of carbapenemase-producing Enterobacteriaceae and Pseudomonas aeruginosa in Romania.
4/2014	Bloodstream infections caused by Pseudomonas spp.: how to detect carbapenemase producers directly from blood cultures.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Laurent Dortet Research Topics

Disease

24	Infections 08/2022 - 08/2011
4	Urinary Tract Infections (Urinary Tract Infection) 01/2022 - 01/2018
3	COVID-19 01/2021 - 12/2020
2	Cross Infection (Nosocomial Infection) 01/2020 - 01/2018
2	Communicable Diseases (Infectious Diseases) 01/2016 - 11/2015
1	Diabetes Mellitus 04/2022
1	Ventilator-Associated Pneumonia 03/2022
1	Respiratory Tract Infections (Respiratory Tract Infection) 01/2021
1	Malaria 01/2021
1	Virus Diseases (Viral Diseases) 01/2021
1	Pseudomonas Infections 01/2021
1	Coronavirus Infections 01/2021
1	Fatigue 01/2021
1	Drug-Related Side Effects and Adverse Reactions 08/2020
1	Wounds and Injuries (Trauma) 10/2019
1	Bacteremia 10/2018
1	Persistent Infection 01/2018
1	Sepsis (Septicemia) 04/2014
1	Endocarditis 11/2013
1	Bacterial Infections (Bacterial Infection) 11/2010

Drug/Important Bio-Agent (IBA)

10	carbapenemaseIBA 02/2022 - 04/2014
7	Pharmaceutical PreparationsIBA 01/2021 - 01/2016
7	Colistin (Coly-Mycin)FDA Link 01/2021 - 10/2018
6	Anti-Bacterial Agents (Antibiotics)IBA 03/2022 - 01/2016
5	Carbapenems (Carbapenem Antibiotics)IBA 01/2022 - 01/2016
3	CefiderocolIBA 08/2022 - 08/2020
2	Linezolid (Zyvox)FDA Link 02/2022 - 01/2020
2	Immunoglobulin M (IgM)IBA 01/2021 - 12/2020
2	Immunoglobulin G (IgG)IBA 01/2021 - 12/2020
2	LactamsIBA 01/2020 - 01/2017
2	ceftazidime drug combination avibactamIBA 10/2019 - 01/2019
2	tazobactam drug combination ceftolozaneIBA 10/2019 - 01/2019
1	Cephalosporins (Cephalosporin Antibiotics)IBA 08/2022
1	catechol (pyrocatechol)IBA 08/2022
1	Amdinocillin (Mecillinam)FDA Link 01/2022
1	AntigensIBA 01/2021
1	FluoroquinolonesIBA 01/2020
1	NitrofuransIBA 01/2020
1	Meropenem (Merrem)FDA LinkGeneric 10/2019
1	Ceftazidime (Fortum)FDA LinkGeneric 10/2019
1	Tazobactam Drug Combination Piperacillin (Zosyn)FDA LinkGeneric 10/2019
1	Imipenem FDA Link 10/2019
1	Clavulanic Acid (Potassium Clavulanate)FDA LinkGeneric 01/2019
1	Tazobactam FDA LinkGeneric 01/2019
1	Amoxicillin (Wymox)FDA LinkGeneric 01/2019
1	Aztreonam FDA LinkGeneric 01/2019
1	avibactamIBA 01/2019
1	Polymyxins (Polymyxin)IBA 12/2018
1	Oxazolidinones (2 Oxazolidone)IBA 01/2018
1	Inosine Monophosphate (IMP)IBA 01/2018
1	AminoglycosidesIBA 01/2017
1	Daptomycin FDA Link 11/2013
1	Vancomycin FDA LinkGeneric 11/2013
1	Membrane Proteins (Integral Membrane Proteins)IBA 01/2012
1	sortase AIBA 08/2011
1	Virulence Factors (Pathogenicity Factors)IBA 08/2011
1	Protein Isoforms (Isoforms)IBA 11/2010
1	Small Interfering RNA (siRNA)IBA 11/2010

Therapy/Procedure

2	Therapeutics 03/2022 - 11/2018
1	Splenectomy 04/2022
1	Ambulatory Care (Outpatient Care) 01/2021